{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T08:00:39Z","timestamp":1769932839248,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T00:00:00Z","timestamp":1226361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s10067-008-1035-5","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T07:32:48Z","timestamp":1226302368000},"page":"277-283","source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis"],"prefix":"10.1007","volume":"28","author":[{"given":"Shunsuke","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumire","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineharu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,11]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"1035_CR2","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA et al (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831\u20131835","journal-title":"Arthritis Rheum"},{"key":"1035_CR3","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/ard.2004.035089","volume":"64","author":"FA Gaalen van","year":"2005","unstructured":"van Gaalen FA, Visser H, Huizinga TW (2005) A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis 64:1510\u20131512","journal-title":"Ann Rheum Dis"},{"key":"1035_CR4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.62.9.870","volume":"62","author":"DM Lee","year":"2003","unstructured":"Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62:870\u2013874","journal-title":"Ann Rheum Dis"},{"key":"1035_CR5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","volume":"67","author":"SW Syversen","year":"2008","unstructured":"Syversen SW, Gaarder PI, Goll GL et al (2008) High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 67:212\u2013217","journal-title":"Ann Rheum Dis"},{"key":"1035_CR6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845\u2013851","journal-title":"Ann Rheum Dis"},{"key":"1035_CR7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"FA Gaalen van","year":"2004","unstructured":"van Gaalen FA, Linn-Rasker SP, van Venrooij WJ et al (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50:709\u2013715","journal-title":"Arthritis Rheum"},{"key":"1035_CR8","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741\u20132749","journal-title":"Arthritis Rheum"},{"key":"1035_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U et al (2006) Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 65:453\u2013458","journal-title":"Ann Rheum Dis"},{"key":"1035_CR10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H Visser","year":"2002","unstructured":"Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357\u2013365","journal-title":"Arthritis Rheum"},{"key":"1035_CR11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2005.038042","volume":"65","author":"D Sene","year":"2006","unstructured":"Sene D, Ghillani-Dalbin P, Limal N et al (2006) Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren\u2019s syndrome. Ann Rheum Dis 65:394\u2013397","journal-title":"Ann Rheum Dis"},{"key":"1035_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.60.1.67","volume":"60","author":"R Mediwake","year":"2001","unstructured":"Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ (2001) Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 60:67\u201368","journal-title":"Ann Rheum Dis"},{"key":"1035_CR13","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/art.20355","volume":"50","author":"MH Wener","year":"2004","unstructured":"Wener MH, Hutchinson K, Morishima C, Gretch DR (2004) Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 50:2305\u20132308","journal-title":"Arthritis Rheum"},{"key":"1035_CR14","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar1041","volume":"6","author":"M Bombardieri","year":"2004","unstructured":"Bombardieri M, Alessandri C, Labbadia G et al (2004) Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 6:R137\u2013R141","journal-title":"Arthritis Res Ther"},{"key":"1035_CR15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE, Mignot S, Nicaise-Rolland P et al (2005) Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren\u2019s syndrome. Ann Rheum Dis 64:114\u2013117","journal-title":"Ann Rheum Dis"},{"key":"1035_CR16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2005.045229","volume":"65","author":"O Elkayam","year":"2006","unstructured":"Elkayam O, Segal R, Lidgi M, Caspi D (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65:1110\u20131112","journal-title":"Ann Rheum Dis"},{"key":"1035_CR17","first-page":"383","volume":"60","author":"WJ Venrooij van","year":"2002","unstructured":"van Venrooij WJ, Hazes JM, Visser H (2002) Anticitrullinated protein\/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 60:383\u2013388","journal-title":"Neth J Med"},{"key":"1035_CR18","first-page":"2390","volume":"33","author":"T Matsui","year":"2006","unstructured":"Matsui T, Shimada K, Ozawa N et al (2006) Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol 33:2390\u20132397","journal-title":"J Rheumatol"},{"key":"1035_CR19","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.21739","volume":"54","author":"AH Helm-van Mil van der","year":"2006","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 54:1117\u20131121","journal-title":"Arthritis Rheum"},{"key":"1035_CR20","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","volume":"52","author":"P Irigoyen","year":"2005","unstructured":"Irigoyen P, Lee AT, Wener MH et al (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 52:3813\u20133818","journal-title":"Arthritis Rheum"},{"key":"1035_CR21","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","volume":"52","author":"TW Huizinga","year":"2005","unstructured":"Huizinga TW, Amos CI, van der Helm-van Mil AH et al (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52:3433\u20133438","journal-title":"Arthritis Rheum"},{"key":"1035_CR22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","volume":"34","author":"A Suzuki","year":"2003","unstructured":"Suzuki A, Yamada R, Chang X et al (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395\u2013402","journal-title":"Nat Genet"},{"key":"1035_CR23","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.22570","volume":"56","author":"S Cha","year":"2007","unstructured":"Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC (2007) Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum 56:1454\u20131463","journal-title":"Arthritis Rheum"},{"key":"1035_CR24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.2004.026831","volume":"64","author":"L Caponi","year":"2005","unstructured":"Caponi L, Petit-Teixeira E, Sebbag M et al (2005) A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 64:587\u2013593","journal-title":"Ann Rheum Dis"},{"key":"1035_CR25","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/ar1889","volume":"8","author":"B Hoppe","year":"2006","unstructured":"Hoppe B, Haupl T, Gruber R et al (2006) Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther 8:R34","journal-title":"Arthritis Res Ther"},{"key":"1035_CR26","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.20169","volume":"50","author":"A Barton","year":"2004","unstructured":"Barton A, Bowes J, Eyre S et al (2004) A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 50:1117\u20131121","journal-title":"Arthritis Rheum"},{"key":"1035_CR27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2003.008623","volume":"63","author":"S Dubucquoi","year":"2004","unstructured":"Dubucquoi S, Solau-Gervais E, Lefranc D et al (2004) Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 63:415\u2013419","journal-title":"Ann Rheum Dis"},{"key":"1035_CR28","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1515\/CCLM.2005.214","volume":"43","author":"A Fernandez-Suarez","year":"2005","unstructured":"Fernandez-Suarez A, Reneses S, Wichmann I, Criado R, Nunez A (2005) Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med 43:1234\u20131239","journal-title":"Clin Chem Lab Med"},{"key":"1035_CR29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1313.031","volume":"1050","author":"A Greiner","year":"2005","unstructured":"Greiner A, Plischke H, Kellner H, Gruber R (2005) Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad Sci 1050:295\u2013303","journal-title":"Ann N Y Acad Sci"},{"key":"1035_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cccn.2004.11.025","volume":"354","author":"B Garcia-Berrocal","year":"2005","unstructured":"Garcia-Berrocal B, Gonzalez C, Perez M et al (2005) Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients. Clin Chim Acta 354:123\u2013130","journal-title":"Clin Chim Acta"},{"key":"1035_CR31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03009740310003677","volume":"32","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Sawada T, Murakami A et al (2003) High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32:197\u2013204","journal-title":"Scand J Rheumatol"},{"key":"1035_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1521-6942(02)00126-2","volume":"17","author":"AN Malaviya","year":"2003","unstructured":"Malaviya AN, Kotwal PP (2003) Arthritis associated with tuberculosis. Best Pract Res Clin Rheumatol 17:319\u2013343","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1035_CR33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/ard.2005.047274","volume":"65","author":"T Yamada","year":"2006","unstructured":"Yamada T, Nakajima A, Inoue E et al (2006) Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 65:1661\u20131663","journal-title":"Ann Rheum Dis"},{"key":"1035_CR34","first-page":"1436","volume":"30","author":"L Carmona","year":"2003","unstructured":"Carmona L, Hernandez-Garcia C, Vadillo C et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30:1436\u20131439","journal-title":"J Rheumatol"},{"key":"1035_CR35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10067-007-0810-z","volume":"27","author":"LS Guedes-Barbosa","year":"2008","unstructured":"Guedes-Barbosa LS, Mangueira C, Scheinberg M (2008) Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association. Clin Rheumatol 27:515\u2013516","journal-title":"Clin Rheumatol"},{"key":"1035_CR36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.2005.049403","volume":"65","author":"D Makrygiannakis","year":"2006","unstructured":"Makrygiannakis D, af Klint E, Lundberg IE et al (2006) Citrullination is an inflammation-dependent process. Ann Rheum Dis 65:1219\u20131222","journal-title":"Ann Rheum Dis"},{"key":"1035_CR37","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/art.11229","volume":"48","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar ER, Nijenhuis S, Helsen MM et al (2003) Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 48:2489\u20132500","journal-title":"Arthritis Rheum"},{"key":"1035_CR38","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","volume":"50","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50:3485\u20133494","journal-title":"Arthritis Rheum"},{"key":"1035_CR39","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.23514","volume":"58","author":"P Kakumanu","year":"2008","unstructured":"Kakumanu P, Yamagata H, Sobel ES, Reeves WH, Chan EK, Satoh M (2008) Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 58:1576\u20131581","journal-title":"Arthritis Rheum"},{"key":"1035_CR40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2006.058933","volume":"66","author":"A Vannini","year":"2007","unstructured":"Vannini A, Cheung K, Fusconi M et al (2007) Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis 66:511\u2013516","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-1035-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-008-1035-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-1035-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:32Z","timestamp":1559105492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-1035-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,11]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-1035-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,11]]}}}